SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : QIAGEN (QGENF) - Star of Germany's Biotechs
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: S. Chandra Shekar who wrote (46)3/15/1998 9:28:00 PM
From: Andreas Helke  Read Replies (2) of 122
 
80 million germans have only 15 small and midcap stocks at their disposal for speculative buying. After its listing on the "Neuer Markt" Quiagen is one of them. Those stocks have a habit of going up 30% or more in a day after a recommendation.
The latest entry a company dealing with ink management of printing machines reached 270% of its IPO price at the first trading day.

I prefer to stay away from that market. It is just too unpredictable and the P/Es are too high for my taste. Of course I would like to get in at the IPO price. And in germany a good part of the shares gets distributed to retail investors. But you are screwed again because too many other investors have the same idea and that leads to massive oversubscription.

Andreas
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News